DrugPatentWatch Database Preview

Heron Theraps Inc Company Profile

HERON THERAPS INC has two approved drugs.

There are eleven US patents protecting HERON THERAPS INC drugs.

There are twenty-two patent family members on HERON THERAPS INC drugs in ten countries and seven supplementary protection certificates in four countries.

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes	8,715,710	➤ Try a Free Trial	Y			➤ Try a Free Trial
Heron Theraps Inc	CINVANTI	aprepitant	EMULSION;INTRAVENOUS	209296-001	Nov 9, 2017		RX	Yes	Yes	9,974,742	➤ Try a Free Trial	Y			➤ Try a Free Trial
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes	8,252,304	➤ Try a Free Trial	Y			➤ Try a Free Trial
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes	8,252,305	➤ Try a Free Trial				➤ Try a Free Trial
Heron Theraps Inc	CINVANTI	aprepitant	EMULSION;INTRAVENOUS	209296-001	Nov 9, 2017		RX	Yes	Yes	9,561,229	➤ Try a Free Trial	Y			➤ Try a Free Trial
Heron Theraps Inc	SUSTOL	granisetron	INJECTION, EXTENDED RELEASE;SUBCUTANEOUS	022445-001	Aug 9, 2016		RX	Yes	Yes		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Australia	2005289425	➤ Try a Free Trial
World Intellectual Property Organization (WIPO)	2006037116	➤ Try a Free Trial
Japan	2017008113	➤ Try a Free Trial
China	101052376	➤ Try a Free Trial
Japan	6057972	➤ Try a Free Trial
European Patent Office	2902012	➤ Try a Free Trial
Country	Patent Number	Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0734381	PA2004002	Lithuania	➤ Try a Free Trial	PRODCUT NAME: 5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(TRIFLUORMETIL)FENIL]ETOKSI]-3-(4-FLUORFENIL)-4-MORFOLINIL]METIL]-1,2-DIHIDRO-3H-1,2,4-TRIAZOL-3-ONAS (APREPITANTAS); REGISTRATION NO./DATE: EU/1/03/262/001-006/20031111
0734381	3/2004	Austria	➤ Try a Free Trial	PRODUCT NAME: APREPITANT, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEMBAREN SALZES; REGISTRATION NO/DATE: EU/1/03/262/001 - EU/1/03/262/006 20031111
0748320	SPC/GB08/021	United Kingdom	➤ Try a Free Trial	PRODUCT NAME: FOSAPREPITANT AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR THE BIS(N-METHYL-D-GLUCAMINE)SALT; REGISTERED: UK EU/1/07/437/001 20080111; UK EU/1/07/437/002 20080111
0748320	08C0019	France	➤ Try a Free Trial	PRODUCT NAME: FOSAPREPITANT DIMEGLUMINE; REGISTRATION NO/DATE: EU/1/07/437/001 20080111
0734381	SPC/GB04/011	United Kingdom	➤ Try a Free Trial	PRODUCT NAME: APREPITANT, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/03/262/001 20031113; UK EU/1/03/262/002 20031113; UK EU/1/03/262/003 20031113; UK EU/1/03/262/004 20031113; UK EU/1/03/262/005 20031113; UK EU/1/03/262/006 20031113
0734381	04C0010	France	➤ Try a Free Trial	PRODUCT NAME: APREPITANT; REGISTRATION NO/DATE: EU/1/03/262/001 20031111
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.